IHH Healthcare Berhad: Key Update on Material Litigation Involving Subsidiary and Daiichi Sankyo

Date Announced: 28 April 2026
Company: IHH Healthcare Berhad
Stock Name: IHH

Key Points for Investors

• Material Litigation: IHH Healthcare’s indirect wholly-owned subsidiary, Northern TK Venture Pte Ltd (“NTK”), has filed a legal claim against Daiichi Sankyo Company, Limited at the Tokyo District Court.
• Scope of Litigation: The litigation is directly related to NTK’s involvement in the acquisition of equity in Fortis Healthcare Limited and Fortis Malar Hospitals Limited through preferential allotment and open offers.
• Judgement Timeline: The Tokyo District Court has concluded preparatory and oral proceedings. The judgement is scheduled to be announced on 10 September 2026.
• Ongoing Updates: IHH has committed to making further announcements if there are any material developments in this litigation.

Details of the Transaction and Litigation

The litigation arises from a broader transaction involving the following components:

1. Subscription: NTK subscribed to 235,294,117 new equity shares in Fortis Healthcare Limited (“Fortis”), each with a face value of INR 10, via preferential allotment. This was a significant move to increase IHH’s influence in Fortis.
2. Mandatory Open Offers:
   • Fortis Open Offer: A mandatory open offer for up to 197,025,660 additional Fortis shares, representing an extra 26.10% of Fortis’ expanded voting share capital, was initiated.
   • Malar Open Offer: A mandatory open offer for up to 4,894,308 fully paid-up equity shares (INR 10 each) of Fortis Malar Hospitals Limited, representing 26.00% of Malar’s voting share capital.
3. The above activities (subscription and open offers) are collectively referred to as the “Transaction”.

IHH has kept shareholders informed about the Transaction through a series of announcements since July 2018, reflecting the material nature and complexity of the ongoing processes and litigation.

What Shareholders Should Know

• Potential Share Price Impact: The outcome of the Tokyo District Court’s judgement, due 10 September 2026, could materially affect IHH’s strategic position and investments in Fortis and Fortis Malar. Any significant court decision—positive or negative—could move IHH’s share price.
• Legal Uncertainty: The proceedings have officially concluded, but the verdict is pending. Investors should be aware of the uncertainty and potential risk until the judgement is delivered.
• Continuous Disclosure: IHH has reaffirmed its commitment to timely disclosure. Any material developments will be announced, which could provide further clarity or market-moving information in the near future.

Conclusion

This litigation update is highly relevant for shareholders and the broader market because it directly relates to IHH’s expansion strategy in India. The impending judgement could have significant implications for IHH’s financial exposure, reputation, and shareholder value. Investors are advised to monitor further announcements closely as the judgement date approaches.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research or consult with their financial advisors before making any investment decisions. The information herein is based on public announcements as of 28 April 2026 and may be subject to change.

View IHH Historical chart here